Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cross-sectional Study to Establish the Point Prevalence of Serotype 19A Pneumococcal Nasopharyngeal Carriage of Fully Vaccinated Children Aged 6-48 Months 7 Years Following Introduction of PCV-13

NCT03102840 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT03102840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03102840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cross-sectional Study to Establish the Point Prevalence of Serotype 19A Pneumococcal Nasopharyngeal Carriage of Fully Vaccinated Children Aged 6-48 Months 7 Years Following Introduction of PCV-13
Lead sponsor
University of Oxford
Phase
Observational
Overall status
Unknown status
Start date
June 26, 2017
Completion date
October 31, 2020
Enrollment
2,400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

streptococcal pneumonia, streptococcus pneumoniae infection, streptococcus pneumoniae, invasive disease